Replimune (REPL) shares slipped in the premarket on Friday after the company announced that the FDA will convene an advisory committee to review its lead drug, RP1, following the regulator's ...

A minimally invasive treatment called GAE is helping people with chronic knee pain get back to gardening, cycling, and other activities without undergoing knee replacement surgery. Early studies ...

Have you heard the good news? Huw Edwards has started a Substack! I know what you’re thinking: it’s about damn time. I couldn’t have waited a second longer to read the thoughts and opinions of the ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...